TrialBMC gastroenterology2020

Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial.

Jae Ho Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.